5-Azacitidine and Trichostatin A induce DNA damage and apoptotic responses in tongue squamous cell carcinoma: An in vitro study

Arch Oral Biol. 2022 Jan:133:105296. doi: 10.1016/j.archoralbio.2021.105296. Epub 2021 Oct 25.

Abstract

Objective: The present in vitro study aims to investigate the potential use of epigenetic inhibitors as treatment modalities in tongue squamous cell carcinoma.

Design: The human tongue squamous cell carcinoma cell line (CAL-27) was cultured and exposed to varying concentrations of 5-Azacitidine (5-Aza) or Trichostatin A (TSA) in the culture medium. The cell apoptosis was evaluated using Annexin V/PI by flow cytometry. To evaluate DNA damage response, γH2AX foci analysis was performed using immunofluorescence. Single cell gel electrophoresis (SCGE) was applied to measure DNA strand breaks. Gene expression was assessed by quantitative real-time PCR.

Results: The results showed that 5-Aza and TSA had apoptotic effects on the SCC cell line at concentrations of 50-200 µM and 0.5-5 µM, respectively. Immunofluorescence analysis showed increased expression of γH2AX, the marker of DNA damage response after treatment of 5-Aza and TSA that was associated with increased DNA strand breaks. The expressions of urokinase plasminogen activator, its receptor and matrix metalloproteinase-2, were significantly reduced in TSA- and 5-Aza-treated cells.

Conclusions: Our results showed that 5-Aza and TSA increase apoptotic and DNA damage response in squamous cell carcinoma cell line while reducing the expression of tumor invasion genes that further indicating the potential therapeutic value of two epigenetic modifiers in squamous cell carcinoma.

Keywords: Azacitidine; DNA damage response; DNA methyltransferase inhibitor; Histone deacethylase inhibitor; Tongue squamous cell carcinoma; Trichostatin A.

MeSH terms

  • Azacitidine / pharmacology
  • Carcinoma, Squamous Cell* / drug therapy
  • Carcinoma, Squamous Cell* / genetics
  • DNA Damage
  • Decitabine
  • Histone Deacetylase Inhibitors / pharmacology
  • Humans
  • Hydroxamic Acids
  • Matrix Metalloproteinase 2
  • Tongue
  • Tongue Neoplasms* / drug therapy
  • Tongue Neoplasms* / genetics

Substances

  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • trichostatin A
  • Decitabine
  • Matrix Metalloproteinase 2
  • Azacitidine